These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8691637)

  • 1. [The cell cycle and the tumor suppressor genes].
    Kobayashi H
    Rinsho Byori; 1996 Jan; 44(1):3-11. PubMed ID: 8691637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of E2F activity by p21Waf1/Cip1.
    Delavaine L; La Thangue NB
    Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.
    Modestou M; Puig-Antich V; Korgaonkar C; Eapen A; Quelle DE
    Cancer Res; 2001 Apr; 61(7):3145-50. PubMed ID: 11306500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule cyclin-dependent kinase modulators.
    Senderowicz AM
    Oncogene; 2003 Sep; 22(42):6609-20. PubMed ID: 14528286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The functions of the cdk-cyclin kinase inhibitor p21WAF1.
    Boulaire J; Fotedar A; Fotedar R
    Pathol Biol (Paris); 2000 Apr; 48(3):190-202. PubMed ID: 10858953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
    Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for the actions of Hsp90 inhibitors and cancer therapy.
    Yamaki H; Nakajima M; Shimotohno KW; Tanaka N
    J Antibiot (Tokyo); 2011 Sep; 64(9):635-44. PubMed ID: 21811259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression.
    Linke SP; Harris MP; Neugebauer SE; Clarkin KC; Shepard HM; Maneval DC; Wahl GM
    Oncogene; 1997 Jul; 15(3):337-45. PubMed ID: 9233768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-independent induction of apoptosis by cyclin-dependent kinase inhibition.
    Shibata Y; Nishimura S; Okuyama A; Nakamura T
    Cell Growth Differ; 1996 Jul; 7(7):887-91. PubMed ID: 8809406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML; LaCava M; Gimenez-Conti IB; Johnson DG; Conti CJ
    Oncogene; 1998 Oct; 17(17):2251-8. PubMed ID: 9811455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle regulators and human hepatocarcinogenesis.
    Hui AM; Makuuchi M; Li X
    Hepatogastroenterology; 1998; 45(23):1635-42. PubMed ID: 9840120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
    Nip J; Hiebert SW
    Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of tumorigenesis caused by tumor suppressor gene].
    Hayashi Y
    Nihon Rinsho; 2000 Jun; 58(6):1231-6. PubMed ID: 10879046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.